相关实验视频

Updated: Jan 9, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

KLHL24突变驱动了中间丝的降解,线粒体功能障碍和心力衰竭患者的纤维化

Veronika Ramovs^1,2, H Sophia Chen^1,3, Athina Patra¹

¹Department of Anatomy and Embryology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, Netherlands.

Cardiovascular research

|December 5, 2025

概括

KLHL24突变通过过度降解心脏细胞中的中间丝蛋白导致心力衰竭. 这项研究揭示了新的机制,并验证了干细胞模型,以了解这种情况.

科学领域:

心血管生物学心血管生物学
分子遗传学分子遗传学
干细胞研究干细胞研究

背景情况:

患有KLHL24突变 (KLHL24mut) 的表皮溶解牛皮细胞患者经历了严重的心脏功能障碍.
KLHL24是一种全方位素-蛋白酶体系统的组成部分,通过过度降解标蛋白质,与心脏病理有关.
虽然已知减少了desmin,但KLHL24mut驱动的心脏病中的其他机制尚未被探索.

研究的目的:

研究KLHL24突变患者心力衰竭的潜在机制.
探索KLHL24mut在心脏细胞病理中的作用,超出了desmin减小.
验证人类诱导多能干细胞 (hiPSC) 模型用于研究KLHL24mut相关心脏病.

主要方法:

综合临床数据与KLHL24mut患者心脏组织的蛋白质组分析.
利用患者衍生的高PSCs分化为心肌细胞 (CMs) 和心脏纤维细胞.
采用了质谱学,流细胞计,免疫光学和西部斑分析.

主要成果:

由hiPSC衍生的CMs的蛋白质谱反映了患者的心脏组织.
KLHL24mut导致中间丝蛋白 (desmin,synemin,vimentin) 和线粒体蛋白的水平降低.
在CMs中观察到线粒体错位化,线粒体的增加,PKA活动的减少和肉髓缩短.

结论:

多个中间丝蛋白的过度蛋白酶依赖性降解在KLHL24mut中导致心脏功能障碍.
由hiPSC衍生的CMs和患者扩散物具有共同的病理特征,揭示了早期疾病机制.
由hiPSC衍生的CM被验证为研究KLHL24mut相关心脏病理学的相关模型.

关键词:

德斯明·德斯明 (Desmin Desmin) 是一个扩展性心肌病变性是指扩展性心肌病变性.在KLHL24HL上在 Synemin 中使用.在Vimentin中,使用了Vimentin.

更多相关视频

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...